These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11746261)
1. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Dong JT; Boyd JC; Frierson HF Prostate; 2001 Nov; 49(3):166-71. PubMed ID: 11746261 [TBL] [Abstract][Full Text] [Related]
2. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer. Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994 [TBL] [Abstract][Full Text] [Related]
3. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers. Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266 [TBL] [Abstract][Full Text] [Related]
4. Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer. Jongsma AP; Piek JM; Zweemer RP; Verheijen RH; Klein Gebbinck JW; van Kamp GJ; Jacobs IJ; Shaw P; van Diest PJ; Kenemans P Mol Pathol; 2002 Oct; 55(5):305-9. PubMed ID: 12354934 [TBL] [Abstract][Full Text] [Related]
5. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer. Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610 [TBL] [Abstract][Full Text] [Related]
6. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas. Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138 [TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer. Afonso A; Emmert-Buck MR; Duray PH; Bostwick DG; Linehan WM; Vocke CD J Urol; 1999 Sep; 162(3 Pt 1):922-6. PubMed ID: 10458409 [TBL] [Abstract][Full Text] [Related]
8. Identification of a I-cM region of common deletion on 13q14 associated with human prostate cancer. Ueda T; Emi M; Suzuki H; Komiya A; Akakura K; Ichikawa T; Watanabe M; Shiraishi T; Masai M; Igarashi T; Ito H Genes Chromosomes Cancer; 1999 Mar; 24(3):183-90. PubMed ID: 10451697 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer. Latil A; Bièche I; Pesche S; Volant A; Valèri A; Fournier G; Cussenot O; Lidereau R Hum Pathol; 1999 Jul; 30(7):809-15. PubMed ID: 10414500 [TBL] [Abstract][Full Text] [Related]
10. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517 [TBL] [Abstract][Full Text] [Related]
11. Allelic loss on 13q in esophageal squamous cell carcinomas from northern China. Huang XP; Wei F; Liu XY; Xu X; Hu H; Chen BS; Xia SH; Han YS; Han YL; Cai Y; Wu M; Wang MR Cancer Lett; 2002 Nov; 185(1):87-94. PubMed ID: 12142083 [TBL] [Abstract][Full Text] [Related]
12. CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer. Latil A; Morant P; Fournier G; Mangin P; Berthon P; Cussenot O Int J Cancer; 2002 Jun; 99(5):689-96. PubMed ID: 12115502 [TBL] [Abstract][Full Text] [Related]
13. Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues. Mutirangura A; Charuruks N; Shuangshoti S; Sakdikul S; Chatsantikul R; Pornthanakasem W; Sriuranpong V; Supiyaphun P; Voravud N Int J Cancer; 1999 Oct; 83(2):210-4. PubMed ID: 10471529 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Gao X; Porter AT; Honn KV Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer. Hyytinen ER; Frierson HF; Sipe TW; Li CL; Degeorges A; Sikes RA; Chung LW; Dong JT Prostate; 1999 Nov; 41(3):190-5. PubMed ID: 10517877 [TBL] [Abstract][Full Text] [Related]
16. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13. Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions. Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263 [TBL] [Abstract][Full Text] [Related]
18. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma. Ittmann MM Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052 [TBL] [Abstract][Full Text] [Related]
20. [Loss of heterozygosity on chromosome 13 in squamous cell carcinomas of the larynx]. Bai S; Zhang X; Wang J Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):35-7. PubMed ID: 10743052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]